S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
3 Overdone Selloffs Offering a Second Chance
By slimmest of margins, Senate takes up $1.9T relief bill
Powell: Higher inflation temporary, no rate hikes in sight
Tech pulls stocks lower as bond yields continue upward march
Shares slip in Asia after bond yield spike hits Wall St
EXPLAINER: Why rising rates are unsettling Wall Street
Cameco Stock is the Real Deal Uranium Play
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
3 Overdone Selloffs Offering a Second Chance
By slimmest of margins, Senate takes up $1.9T relief bill
Powell: Higher inflation temporary, no rate hikes in sight
Tech pulls stocks lower as bond yields continue upward march
Shares slip in Asia after bond yield spike hits Wall St
EXPLAINER: Why rising rates are unsettling Wall Street
Cameco Stock is the Real Deal Uranium Play
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
3 Overdone Selloffs Offering a Second Chance
By slimmest of margins, Senate takes up $1.9T relief bill
Powell: Higher inflation temporary, no rate hikes in sight
Tech pulls stocks lower as bond yields continue upward march
Shares slip in Asia after bond yield spike hits Wall St
EXPLAINER: Why rising rates are unsettling Wall Street
Cameco Stock is the Real Deal Uranium Play
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
3 Overdone Selloffs Offering a Second Chance
By slimmest of margins, Senate takes up $1.9T relief bill
Powell: Higher inflation temporary, no rate hikes in sight
Tech pulls stocks lower as bond yields continue upward march
Shares slip in Asia after bond yield spike hits Wall St
EXPLAINER: Why rising rates are unsettling Wall Street
Cameco Stock is the Real Deal Uranium Play
Log in
NYSEARCA:BIL

SPDR Bloomberg Barclays 1-3 Month T-Bill ETF Stock Forecast, Price & News

$91.51
0.00 (0.00 %)
(As of 03/4/2021 12:00 AM ET)
Add
Today's Range
$91.50
Now: $91.51▼
$91.51
50-Day Range
$91.50
MA: $91.51▼
$91.52
52-Week Range
$91.50
Now: $91.51▼
$95.96
Volume1.45 million shs
Average Volume1.49 million shs
Market Capitalization$12.34 billion
P/E RatioN/A
Dividend Yield0.18%
BetaN/A

Basic Details

Issuer SSgA
Fund NameSPDR Bloomberg Barclays 1-3 Month T-Bill ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:BIL
Inception Date5/25/2007
Fund ManagerTodd Bean, Sean Lussier
WebN/A
PhoneN/A

Fund Focus

Asset ClassFixed Income
BenchmarkBarclays Capital U.S. 1-3 Month Treasury Bill Index
CategoryU.S. Government
FocusTreasury
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$13.87 billion
Average Daily Volume$1.80 million
Discount/Premium-0.01%

ETF Expenses

Management Fee0.14%
Other Expenses0.00%
Total Expenses0.14%
Fee Waiver0.00%
Net Expenses0.14%

Administrator, Advisor and Custodian

AdministratorSSgA Funds Management, Inc.
AdvisorSSgA Funds Management, Inc.
CustodianState Street Bank and Trust Company
DistributorState Street Global Advisors Funds Distributors, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market MakerJane Street

Geographic Exposure of BIL

Currency Exposure of BIL

$91.51
0.00 (0.00 %)
(As of 03/4/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BIL News and Ratings via Email

Sign-up to receive the latest news and ratings for BIL and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











SPDR Bloomberg Barclays 1-3 Month T-Bill ETF (NYSEARCA:BIL) Frequently Asked Questions

What stocks does MarketBeat like better than SPDR Bloomberg Barclays 1-3 Month T-Bill ETF?

Wall Street analysts have given SPDR Bloomberg Barclays 1-3 Month T-Bill ETF a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but SPDR Bloomberg Barclays 1-3 Month T-Bill ETF wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has SPDR Bloomberg Barclays 1-3 Month T-Bill ETF's stock been impacted by COVID-19 (Coronavirus)?

SPDR Bloomberg Barclays 1-3 Month T-Bill ETF's stock was trading at $91.59 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, BIL shares have decreased by 0.1% and is now trading at $91.51.
View which stocks have been most impacted by COVID-19.

Is SPDR Bloomberg Barclays 1-3 Month T-Bill ETF a good dividend stock?

SPDR Bloomberg Barclays 1-3 Month T-Bill ETF pays an annual dividend of $0.17 per share and currently has a dividend yield of 0.18%.
View SPDR Bloomberg Barclays 1-3 Month T-Bill ETF's dividend history.

What other stocks do shareholders of SPDR Bloomberg Barclays 1-3 Month T-Bill ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SPDR Bloomberg Barclays 1-3 Month T-Bill ETF investors own include AbbVie (ABBV), QUALCOMM (QCOM), Intel (INTC), Netflix (NFLX), Pfizer (PFE), iShares iBoxx $ Investment Grade Corporate Bond ETF (LQD), Alibaba Group (BABA), Bristol-Myers Squibb (BMY), The Home Depot (HD) and Lockheed Martin (LMT).

What is SPDR Bloomberg Barclays 1-3 Month T-Bill ETF's stock symbol?

SPDR Bloomberg Barclays 1-3 Month T-Bill ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "BIL."

How do I buy shares of SPDR Bloomberg Barclays 1-3 Month T-Bill ETF?

Shares of BIL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is SPDR Bloomberg Barclays 1-3 Month T-Bill ETF's stock price today?

One share of BIL stock can currently be purchased for approximately $91.51.

How much money does SPDR Bloomberg Barclays 1-3 Month T-Bill ETF make?

SPDR Bloomberg Barclays 1-3 Month T-Bill ETF has a market capitalization of $12.34 billion.


This page was last updated on 3/5/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.